Search clinical trials for: Favorable Intermediate Risk
Total 16117 results
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Washington University School of MedicineCTI BioPharmaWithdrawnMyelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Myeloproliferative Neoplasm | Atypical Chronic Myeloid Leukemia
-
National Cancer Institute, NaplesCompleted
-
International Consortium on Acute LeukemiasUnknown
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia OrganisationCompleted
-
GlaxoSmithKlineCompletedAtrial Fibrillation | Fibrillation, AtrialSpain, United States, Taiwan, Estonia, Canada, Sweden, Thailand, Germany, Korea, Republic of, Latvia, Romania, Argentina, Belgium, France, India, Netherlands, New Zealand, Italy, Norway, United Kingdom, Greece, Hungary, Denmark, Brazil, Mexic...
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedCardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | HypercholesterolemiaUnited States, Canada
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; CelgeneCompletedMyelodysplastic SyndromesFrance, Monaco
-
Meshalkin Research Institute of Pathology of CirculationUnknownPulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and SildenafilRussian Federation
-
Hospices Civils de LyonUnknown
-
Johnson & Johnson Pharmaceutical Research & Development...Ortho Biotech Clinical Affairs, L.L.C.Withdrawn
-
Hospices Civils de LyonUnknownProstate CancerFrance
-
University of ZurichTerminatedMitral Valve InsufficiencyGermany, Italy, Switzerland
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
Apogenix GmbHCompleted
-
Sophiris Bio CorpCompletedProstate CancerUnited Kingdom
-
CureVacTerminated
-
Roswell Park Cancer InstituteGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
Albert DeNittisUnknown
-
Fox Chase Cancer CenterGenentech, Inc.WithdrawnStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Stage I Adult Diffuse Large Cell LymphomaUnited States
-
Chiang Mai UniversityCompleted
-
Asociación Andaluza de Hematología y HemoterapiaCompleted
-
SanofiCompletedHematopoietic NeoplasmAustria, Germany, Italy, Spain, United Kingdom, France, Belgium, Israel, Sweden, Australia, United States, Lithuania, Portugal, Korea, Republic of, Singapore, Taiwan, Mexico, Brazil, Canada, Hungary, Ireland, Poland, Romania, Russian... and more
-
Assistance Publique Hopitaux De MarseilleUnknown
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineWithdrawnLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, B-Cell, Marginal Zone | Lymphoma, Low-Grade | Lymphoma, Intermediate-Grade
-
University of WaterlooGrand River Regional Cancer CentreCompleted
-
The Affiliated Hospital of the Chinese Academy...Completed
-
Groupe Francophone des MyelodysplasiesCelgene CorporationUnknownAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeFrance
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Ginna LaportTerminatedAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors | Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Myelodysplastic Syndrome (MDS) - High and Intermediate Risk | Non-Hodgkin's Lymphoma (NHL) | Chronic Lymphocytic Leukemia...United States
-
Technical University of MunichCompletedStroke | Angina Pectoris | Deep Vein Thrombosis | Pulmonary Embolism | Congestive Heart Failure | Cardiac DeathGermany
-
Southern California Institute for Research and...UnknownObstructive Sleep Apnea | Pulmonary Hypertension
-
Prince of Songkla UniversityCompletedCommon Bile Duct CalculiThailand
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedNon Muscle Invasive Bladder Cancer
-
Hospital de CrucesUnknown
-
Eisai Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Janssen Research & Development, LLCTerminatedMyelodysplastic SyndromeUnited States, Belgium, Spain, Australia, Sweden, Netherlands, Russian Federation
-
Prof. Paolo BruzziUnknown
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
Vancouver Coastal HealthLotte & John Hecht Memorial FoundationTerminated
-
University of ConnecticutNational Institute on Drug Abuse (NIDA); APT Foundation, Inc.CompletedHIV | Opioid DependenceUnited States
-
Riverside Community Hospital, CaliforniaUnknownProstate CancerUnited States